🗞️ACCC's Preliminary Concerns on Sigma's Proposed Acquisition of Chemist Warehouse

Today’s email is brought to you by Empower your podcasting vision with a suite of creative solutions at your fingertips.

The Australian Competition and Consumer Commission (ACCC) has identified preliminary concerns regarding the competitive impact of Sigma Healthcare Limited's proposed acquisition of Chemist Warehouse Group Holdings (ASX: SIG) in a recently released Statement of Issues.

The Background

Sigma is acquiring Chemist Warehouse in a reverse acquisition, which will result in Chemist Warehouse being listed on the ASX. Following the merger, Chemist Warehouse shareholders will collectively hold 85% of the merged entity, while Sigma shareholders will hold 14.75%.

ACC

The Australian Competition and Consumer Commission (ACCC) is concerned that the proposed acquisition could have a detrimental impact on pharmacies currently supplied by Sigma, resulting in a notable reduction in competition in pharmacy retailing.

Additionally, the ACCC is concerned that the merger may facilitate Chemist Warehouse's access to and exploitation of sensitive data about pharmacies supplied by Sigma, which could potentially impede competition.

The ACCC is concerned that the acquisition may reduce competition in pharmacy retailing by influencing the competitive landscape between Chemist Warehouse and Sigma's banner stores.

Sigma

Sigma is one of the largest wholesalers of prescription medicines, over-the-counter medications, and front-of-store products such as health and beauty items. Additionally, Sigma offers brand and support services to community pharmacies that operate as franchisees under Sigma banners, including Amcal +, Discount Drug Stores, PharmaSave, and Guardian.

Chemist Warehouse

Chemist Warehouse is a franchisor of pharmacies and retail stores under the brands Chemist Warehouse, MyChemist, Ultra Beauty, My Beauty Spot, and Optometrist Warehouse. Furthermore, it offers brand and support services to its franchisee pharmacies.

Why does this matter?

This is significant because an understanding of the structure and operations of these major pharmacy chains can provide insights into the competitive landscape of the pharmaceutical industry. This, in turn, can influence consumer access to medications and healthcare products to a considerable extent. Moreover, an understanding of the various services and support provided by these chains can empower consumers to make informed decisions about where to purchase their medications and health products.

Got a News Tip?

Contact our editor via Proton Mail encrypted, X Direct Message, LinkedIn, or email. You can securely message him on Signal by using his username, Miko Santos.

More on The Evening Post AU

• Get Evening Post Wrap - for nighly bite size news around Australia and the world.

• Podwires Daily - for providing news about audio trends and podcasts.

• Podwires Asia - for reporting on podcasting and audio trends in South East Asia

• There’s a Glitch - updated tech news and scam and fraud trends

• Manpalikha - The world's and Asia's most inventive advertisements and news.

• The Freeman Chronicle Podcast - features expert interviews on current political and social issues in Australia and worldwide.

• That Podcast Exchange - This podcast is an insightful conversation with people at the top of their game and deconstructs them to find the tools, tactics, and tricks to help you achieve your dream goal as Podcast Manager.

The Evening Post AU readers receive journalism free of financial and political influence.

We set our own news agenda, which is always based on facts rather than billionaire ownership or political pressure. Despite the financial challenges that our industry faces, we have decided to keep our reporting open to the public because we believe that everyone has the right to know the truth about the events that shape their world.Thanks to the support of our readers, we can continue to provide free reporting. If you can, please choose to support The Evening Post Australia.